VYNE THERAPEUTICS INC. |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.450 USD | -7.20% |
|
-10.26% | +5.15% |
| Nov. 18 | BTIG Initiates VYNE Therapeutics at Buy With $8 Price Target | MT |
| Nov. 07 | Earnings Flash (VYNE) VYNE THERAPEUTICS Reports Q3 Revenue $121,000 | MT |
Chart calendar VYNE Therapeutics Inc.
d480586bd43e23689deb19dfd38a482b.HwlpkBvhU0PkIB-U93mpc8J5WTDL2t-QqljtqAMDW4A.XX4E3VajGRuubyzewybtPKY7bGeMjI7ixjau8Gl2DrV3OCzCK9I-dYZtRg~61c4b7834a24a28fbbafc3478b9e097d
Upcoming events on VYNE Therapeutics Inc.
Past events on VYNE Therapeutics Inc.
| 2024-11-07 08:00 am | Q3 2024 Earnings Release |
| 2024-09-17 08:30 am | Stifel Immunology and Inflammation Virtual Summit |
| 2024-09-08 | H.C. Wainwright Global Investment Conference |
| 2024-08-14 08:00 am | Q2 2024 Earnings Release |
| 2024-07-08 | Leerink Partners Therapeutics I&I and Metabolism Forum |
| 2024-05-18 11:00 am | Society for Investigative Dermatology Meeting |
| 2024-05-16 06:00 pm | Society for Investigative Dermatology Meeting |
| 2024-05-09 08:00 am | Q1 2024 Earnings Release |
| 2024-03-28 08:30 am | H.C. Wainwright Autoimmune & Inflammatory Disease Virtual Conference |
| 2024-03-07 12:06 pm | Global Vitiligo Foundation Scientific Symposium |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-29 08:00 am | Q4 2023 Earnings Release |
| 2023-12-13 10:00 am | Annual General Meeting |
| 2023-11-13 07:45 am | Q3 2023 Earnings Release |
| 2023-11-09 01:30 pm | R&D Day |
| 2023-09-11 07:00 am | H.C. Wainwright Global Investment Conference |
| 2023-08-14 08:00 am | Q2 2023 Earnings Release |
| 2023-06-04 | BIO International Convention |
| 2023-05-11 04:01 pm | Q1 2023 Earnings Release |
| 2023-03-30 03:30 pm | H.C. Wainwright Autoimmune & Inflammatory Disease Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 14,8 17,3 -14.51% | 0,48 0,37 30.09% | 0,42 0,50 -15.2% | 0,55 | 0,25 | 0,30 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | -29,3 -29,7 1.49% | -45,5 | -54,4 | -62,0 |
|
EBIT Million USD | Released Forecast Spread | -68,0 -65,9 -3.17% | -34,3 -36,6 6.17% | -29,3 -32,2 9% | -44,9 | -55,3 | -61,6 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -73,8 -72,2 -2.26% | -33,9 -30,3 -12.17% | -27,9 -28,7 2.89% | -40,5 | -53,3 | -61,4 |
|
Net income Million USD | Released Forecast Spread | -73,3 -72,2 -1.63% | -23,2 -23,8 2.27% | -28,5 -28,7 0.86% | -40,5 | -53,3 | -61,4 |
|
EPS USD | Released Forecast Spread | -25,6 -24,7 -3.4% | -7,28 -8,52 14.55% | -2,78 -4,82 42.32% | -0,96 | -1,13 | -1,16 |
| Announcement Date | 17/03/22 | 09/03/23 | 29/02/24 | - |
Quarterly results
| Fiscal Period | September | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,10 0,00 - | 0,14 0,05 170% | 0,11 0,15 -24% | 0,08 0,15 -49.33% | 0,10 0,10 -2% | 0,20 0,11 80% | 0,12 0,11 10% | 0,14 | 0,10 | 0,10 | 0,10 | 0,10 |
|
EBITDA Million USD | Released Forecast Spread | -6,23 -10,8 42.28% | -6,83 -7,30 6.41% | -7,38 -8,10 8.89% | -10,4 -8,50 -22.31% | -13,1 -9,70 -34.96% | -14,7 | ||||||
|
EBIT Million USD | Released Forecast Spread | -5,88 -8,45 30.47% | -10,3 -10,6 2.66% | -13,4 | -13,6 | -13,9 | -14,2 | -14,5 | |||||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,61 -8,40 33.19% | -10,0 -8,70 -15.38% | -6,07 -10,6 42.73% | -6,15 -7,00 12.11% | -9,40 -8,10 -15.99% | -12,2 -9,20 -32.14% | -12,7 | -12,7 | -13,0 | -13,2 | -13,5 | |
|
Net income Million USD | Released Forecast Spread | -5,62 -8,40 33.07% | -10,1 -8,70 -15.61% | -6,58 -10,6 37.89% | -6,19 -7,00 11.6% | -6,25 | -9,41 -8,10 -16.12% | -12,2 -9,20 -32.14% | -12,7 | -12,7 | -13,0 | -13,2 | -13,5 |
|
EPS USD | Released Forecast Spread | -1,74 -2,61 33.33% | -3,09 -2,58 -19.77% | -2,01 -0,76 -164.47% | -0,20 -0,50 60% | -0,15 | -0,22 -0,19 -15.79% | -0,29 -0,24 -23.4% | -0,30 | -0,29 | -0,30 | -0,30 | -0,31 |
| Announcement Date | 11/05/23 | 14/08/23 | 13/11/23 | 29/02/24 | 09/05/24 | 14/08/24 | 07/11/24 | - | - | - | - | - |
More events
Past sector events for VYNE Therapeutics Inc.
| 2024-12-09 06:16 am | LUMOSA THERAPEUTICS CO., LTD.: November 2024 Sales and Revenue Release |
| 2024-12-05 04:03 am | PHARMAESSENTIA CORPORATION: November 2024 Sales and Revenue Release |
| 2024-11-26 04:00 pm | ARROWHEAD PHARMACEUTICALS, INC.: Q4 2024 Earnings Release |
| 2024-11-24 | ANAVEX LIFE SCIENCES CORP.: Q4 2024 Earnings Release (Projected) |
| 2024-11-18 07:00 am | IMMATICS N.V.: Q3 2024 Earnings Release |
| 2024-11-14 04:01 pm | CELCUITY INC.: Q3 2024 Earnings Release |
| 2024-11-14 04:01 pm | ASCENDIS PHARMA A/S: Q3 2024 Earnings Release |
| 2024-11-14 08:00 am | ANNEXON, INC.: Q3 2024 Earnings Release |
| 2024-11-14 04:09 am | PHARMAESSENTIA CORPORATION: Q3 2024 Earnings Release |
| 2024-11-13 | PEPTRON, INC.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- VYNE Stock
- Calendar VYNE Therapeutics Inc.